• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Gudjon_Iceland

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Forum Replies Created

Viewing 1 post (of 1 total)
  • Author
    Posts
  • September 29, 2016 at 10:06 pm in reply to: Newcomer #2167
    Gudjon_Iceland
    Participant

      Greetings to you as well my dear friends from Turkey and around the world.

    • Author
      Posts
    Viewing 1 post (of 1 total)

    Primary Sidebar

    Advocacy

    • Advocacy Toolkit

    Approved Drugs

    • Nuedexta
    • Radicava/Edaravone
    • Riluzole/Tiglutik
    • Rozebalamin/Methylcobalamin
    • Tofersen/Qalsody

    Drugs in Development

    • AB Science – Masitinib
    • BrainStorm Cell Therapeutics – NurOwn
    • Clene Nanomedicine – CNM-Au8
    • ILB – Tikomed
    • Kadimastem – AstroRx
    • Methylcobalamin
    • Mitsubishi Tanabe Pharma America – Oral Edaravone
    • Neuronata-R/Lenzumestrocel
    • NeuroSense – PrimeC
    • Neuvivo – NP001
    • Prilenia Therapeutics – Pridopidine
    • SOD1 Therapies & Trials
    • SPG302
    • T Regulatory Cell Therapies
    • Ulefnersen – Ionis Pharmaceuticals

    Care services

    • Genetic Counselling & Testing
    • Mental Health Support
    • Nursing and Symptom Management
    • Nutrition and Swallowing
    • Occupational Therapy and Activities of Daily Living
    • Physiotherapy and Mobility
    • Respiratory Care
    • Speech Therapy and Communication
    • Support for Family & Caregivers
    • Technology

    Support for members

    • Alliance Support Grant
    • About the meetings

    Events/Programs

    • Calendar of Events/Programs
    • Alliance Webinars
    • Alliance Meeting
    • Allied Professionals Forum
    • ALS/MND Connect
    • Global Day Calendar
    • March of Faces
    • International Symposium

    About

    • Who We Are
    • Board of Trustees
    • Councils, Forums & Committees
      • PALS and CALS Advisory Council
      • Scientific Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
      • Newsletters
      • Meetings
    • Awards

    Upcoming Events

    Jul 23
    1:00 pm - 2:00 pm EDT

    Traveling with ALS: What to Know Before You Go

    Aug 19
    8:00 am - 9:00 am EDT

    Member Forum: Equitable Access to Care

    Aug 19
    6:00 pm - 7:00 pm EDT

    Member Forum: Equitable Access to Care

    Sep 8
    8:00 am - 9:00 am EDT

    Member Forum: Health Literacy

    Sep 8
    6:00 pm - 7:00 pm EDT

    Member Forum: Health Literacy

    View Calendar

    • Fabrice Kamp, Germany

      Fabrice Kamp, Germany

    • Francisco Perez Palop, Spain

      Francisco Perez Palop, Spain

    • Eddy LeFrançois, Canada

      Eddy LeFrançois, Canada

    • Antonio Ventriglia, Belgium

      Antonio Ventriglia, Belgium

    • Margreth Burger-Saile, Switzerland

      Margreth Burger-Saile, Switzerland

    • Chris McCauley, Canada

      Chris McCauley, Canada

    • Hanne Stenmose, Denmark

      Hanne Stenmose, Denmark

    • Timmy, Belgium

      Timmy, Belgium

    • Daniela Maria Daverio, Argentina

      Daniela Maria Daverio, Argentina

    • Mike Small, UK

      Mike Small, UK

    • Kirsty Gerlach, New Zealand

      Kirsty Gerlach, New Zealand

    • Fabio Carvalho, Brazil

      Fabio Carvalho, Brazil

    • Jo Knowlton, Scotland

      Jo Knowlton, Scotland

    • Chirag Walia, India

      Chirag Walia, India
      ChiragWalia

    • Oliver Juenke, Germany

      Oliver Juenke, Germany

    • Danny Reviers, Belgium

      Danny Reviers, Belgium
      DannyReviers

    • Bob Simonds, USA

      Bob Simonds, USA

    • Jose Espinosa, Argentina

      Jose Espinosa, Argentina

    • Rosie Riley, USA

      Rosie Riley, USA

    • Yessenia Hernandez Mendoza, Mexico

      Yessenia Hernandez Mendoza, Mexico

    • Carlos Alberto Báez Murillo, Colombia

      Carlos Alberto Báez Murillo, Colombia

    • Sally Pauls, USA

      Sally Pauls, USA

    • Sanjay Kumar Srivastava, India

      Sanjay Kumar Srivastava, India

    • Greg Heydet, USA

      Greg Heydet, USA

    • Andrietta, Italy

      Andrietta, Italy
      Andrietta

    • Mirca Bersani, Italy

      Mirca Bersani, Italy
      MircaBersani

    • Paul Launer, USA

      Paul Launer, USA

    • Irene McCaughey, Australia

      Irene McCaughey, Australia

    • Feng Gin Sun, China

      Feng Gin Sun, China

    • Cath Muir, UK

      Cath Muir, UK
      Cath

    • Mikey Stone, ALS

      Mikey Stone, ALS

    • Hollister

      Hollister
      hollister

    • Andres Estevez Guersznik, Ireland

      Andres Estevez Guersznik, Ireland

    • Oliver Juenke, Germany

      Oliver Juenke, Germany

    • Liz Ogg, Scotland

      Liz Ogg, Scotland

    • Ana María Zavala, Mexico

      Ana María Zavala, Mexico

    • Eddy Lefrancois, Canada

      Eddy Lefrancois, Canada

    • Fayette Underwood, USA

      Fayette Underwood, USA

    • Mike Cels, Canada

      Mike Cels, Canada

    • Art Eggert, USA

      Art Eggert, USA

    • David Watson, Scotland

      David Watson, Scotland

    • Shay Rishoni, Israel

      Shay Rishoni, Israel

    • Emilienne Verhaegen, Belgium

      Emilienne Verhaegen, Belgium

    • Fernando Ocampo Cardona, Colombia

      Fernando Ocampo Cardona, Colombia

    • Ann Nicol, USA

      Ann Nicol, USA

    • Enzo Maccarrone, Italy

      Enzo Maccarrone, Italy

    • Joy Blakeley, Australia

      Joy Blakeley, Australia

    • Glen Victor Peters, Australia

      Glen Victor Peters, Australia

    • Chih Ching Darren Wong, Malaysia

      Chih Ching Darren Wong, Malaysia

    • Zelina Brito, Brazil

      Zelina Brito, Brazil

    Learn more about the March of Faces

    Coronavirus (COVID-19) Resources

    Instructions

    First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

    If you have already registered, please use the details provided to log in using this form.

    Drugs No Longer in Development

    • Amylyx – AMX0035
    • Collaborative Medicinal Development – CuATSM
    • Cytokinetics – Reldesemtiv
    • Orphazyme – Arimoclomol
    • TUDCA Trial

    Footer

    Stay connected to the global ALS/MND community.

    Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

     
    This field is for validation purposes and should be left unchanged.
    • Email
    • Facebook
    • LinkedIn
    • Twitter
    • YouTube
    Return to top of page

    Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

    Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


    Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login